UA84737C2 - Imidazoline derivatives having cb1-antagonistic activity - Google Patents

Imidazoline derivatives having cb1-antagonistic activity

Info

Publication number
UA84737C2
UA84737C2 UAA200610009A UAA200610009A UA84737C2 UA 84737 C2 UA84737 C2 UA 84737C2 UA A200610009 A UAA200610009 A UA A200610009A UA A200610009 A UAA200610009 A UA A200610009A UA 84737 C2 UA84737 C2 UA 84737C2
Authority
UA
Ukraine
Prior art keywords
imidazoline derivatives
antagonistic activity
compounds
preparation
methods
Prior art date
Application number
UAA200610009A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Йозефус Г.М. Ланге
Корнелис Г. Крузе
Стёйвенберг Герман Г. ван
Original Assignee
Сольве Фармасьютикалз Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сольве Фармасьютикалз Б.В. filed Critical Сольве Фармасьютикалз Б.В.
Publication of UA84737C2 publication Critical patent/UA84737C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention relates to 1,2,4-tri-substituted imidazoline derivatives, to methods for the preparation of these compounds, to novel intermediates useful for the synthesis of said imidazoline derivatives, to methods for the preparation of these intermediates, to pharmaceutical compositions containing one or more of these imidazoline derivatives as active ingredient, as well as to the use of these pharmaceutical compositions for the treatment of psychiatric and neurological disorders. The compounds have the general formula (I) wherein the symbols have the meaningsgiven in the specification.
UAA200610009A 2004-02-19 2005-02-16 Imidazoline derivatives having cb1-antagonistic activity UA84737C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04100656 2004-02-19

Publications (1)

Publication Number Publication Date
UA84737C2 true UA84737C2 (en) 2008-11-25

Family

ID=34928876

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200610009A UA84737C2 (en) 2004-02-19 2005-02-16 Imidazoline derivatives having cb1-antagonistic activity

Country Status (7)

Country Link
CN (1) CN101076520B (en)
AR (1) AR047613A1 (en)
BR (1) BRPI0507269A (en)
SA (1) SA05260008B1 (en)
TW (1) TWI335321B (en)
UA (1) UA84737C2 (en)
ZA (1) ZA200606123B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1429761T1 (en) * 2001-09-21 2007-02-28 Solvay Pharm Bv Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
TWI231757B (en) * 2001-09-21 2005-05-01 Solvay Pharm Bv 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
AR038966A1 (en) * 2002-03-18 2005-02-02 Solvay Pharm Bv DERIVATIVES OF TIAZOL THAT HAVE ANTAGONIST, AGONIST OR PARTIAL AGONIST ACTIVITY OF CB1
US6878735B2 (en) * 2002-05-31 2005-04-12 Board Of Trustees Of Michigan State University Multi-substituted imidazolines and method of use thereof

Also Published As

Publication number Publication date
TW200530191A (en) 2005-09-16
CN101076520A (en) 2007-11-21
SA05260008A (en) 2005-12-03
CN101076520B (en) 2011-06-01
BRPI0507269A (en) 2007-06-26
ZA200606123B (en) 2007-11-28
AR047613A1 (en) 2006-01-25
TWI335321B (en) 2011-01-01
SA05260008B1 (en) 2007-10-29

Similar Documents

Publication Publication Date Title
IL176546A0 (en) Imidazoline derivatives having cb1-antagonistic activity
MY140693A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
TW200517388A (en) Thiazole derivatives as cannabinoid receptor modulators
TW200635903A (en) Therapeutic agents
MY138478A (en) Benzazepine derivatives for the treatment of neurological disorders
AP1822A (en) Substituted pyridinones as modulators of P38 MAP kinase.
TW200531689A (en) Therapeutic agents
IL187438A0 (en) Pyrrolopyridine derivatives and pharmaceutical compositions containing the same
TW200504034A (en) Therapeutic agents
TW200503713A (en) Novel compounds
TW200503710A (en) Novel compounds
UA92503C2 (en) 5-(phenylisoxazolylethoxy)-triazol-3-yl-substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders
TW200633986A (en) Therapeutic agents
WO2004009549A3 (en) Piperidines useful for the treatment of central nervous system disorders
TW200611695A (en) Pyrrolopyridine derivatives
HK1069169A1 (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
GB0513886D0 (en) Novel compounds
TW200514781A (en) Novel compounds
TW200509933A (en) Therapeutic agents
UA84896C2 (en) Hydronopol derivatives as agonists on human orl1 receptors
TW200734324A (en) Therapeutic agents
EP1736470A3 (en) Pyrimidine derivatives as CB2 cannabinoid receptor modulators
MXPA05004273A (en) Phenylalkyl and pyridylalkyl piperazine derivatives.
IL173436A0 (en) 1h-imidazole derivatives as cannabinoid receptor modulators